MedTrace Logo

Minority-focused Environmental Health Education and Tracking Pilot Study

NCT07461857 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 151

Last updated 2026-05-18

No results posted yet for this study

Summary

The goal of this study is identify educational material related to EDC exposures that is culturally appropriate for the black community and test the usability of the material. The main questions this study aims to answer are:

1. identify problematic lifestyle behaviors and products in a minority population that may contribute to harmful exposures and subsequently determine the most effective and sustainable lifestyle recommendations to reduce exposures;
2. develop culturally appropriate educational EDC EHL materials by collaborating with community groups and adapting from Million Marker's existing extensive online educational resources and recommendations;
3. integrate developed educational materials and targeted recommendations in existing Million Marker platform and test the usability of the material using a cohort of 100 black community members.

Conditions

  • Environmental Exposure

Interventions

BEHAVIORAL

Education curriculum

A self-directed online interactive curriculum of EDC material, with access to live coaches and an online forum.

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Million Marker Wellness, Inc.

    lead INDUSTRY

Principal Investigators

  • Jayne Foley, MPPM, MPH · Million Marker Wellness

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2026-02-20
Completion
2026-02-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07461857 on ClinicalTrials.gov